https://shroomcity.com/2021/12/08/cybin-gets-approval-for-phase-2-trial/
Cybin Gets Approval for Phase 2 Trial - Let's Grow Together!
Oct 5, 2022 - Cybin has just announced that the FDA has authorized a Phase 2 clinical trial evaluating psychedelic-assisted psychotherapy with psilocybin for frontline...
cybingetsapprovalphase
https://sharedata.co.za/v2/Scripts/Chart.aspx?c=CCC&x=JSE
CCC Cilo Cybin Holdings Ltd. Interactive Chart
Chart page for CILOCYBIN | CCC | Cilo Cybin Holdings Ltd. with daily closing prices and technical indicators
ccccilocybinholdingsltd
https://biotech-365.com/cybin-initiates-at-the-market-equity-program-of-up-to-us100-million/
Cybin Initiates At-The-Market Equity Program of up to US$100 Million | Biotech 365
https://www.pharmiweb.com/press-release/2021-03-09/cybin-announces-api-synthesis-and-optimization-of-multiple-tryptamine-derivatives-and-nomination-of
Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF)...
cybinannouncesapisynthesis
https://psychedelicspotlight.com/how-cybin-is-revolutionizing-mental-healthcare-with-novel-psychedelic-compounds/
How Cybin Is 'Revolutionizing' Healthcare with Psychedelic Compounds
Jun 2, 2024 - Cybin CEO Doug Drysdale shares the company's strategy for widespread mental healthcare with accessible psychedelic-assisted therapy.
revolutionizing healthcarecybinpsychedeliccompounds
https://www.missionir.com/cybin-inc-cybn/cybin-inc-neo-cybn-nyse-american-cybn-on-leading-edge-of-development-of-psychedelics-as-public-support-grows/
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) on Leading Edge of Development of Psychedelics as...
Mar 17, 2022 - More than 60% of American who suffer from mental health conditions want access to psychedelic options Growing number of cities, states looking at...
https://alps-holdings.com/tag/cilo-cybin-holdings/
Cilo Cybin Holdings Archives - ALPS Group Inc.
cilocybinholdingsarchivesalps